Short-term change in kidney function and risk of end-stage renal disease

Nephrology Dialysis Transplantation

Volumn 27, Issue 10, 2012, Pages 3835-3843

  Turin, Tanvir Chowdhury ^a   Coresh, Josef ^b   Tonelli, Marcello ^c   Stevens, Paul E ^d   De Jong, Paul E ^e   Farmer, Christopher K T ^d   Matsushita, Kunihiro ^b   Hemmelgarn, Brenda R ^a,f  

^a UNIVERSITY OF CALGARY   (Canada)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

change in eGFR; chronic kidney disease; CKD stages; end stage renal disease; population

Indexed keywords

CREATININE;

ADULT; AGE DISTRIBUTION; ARTICLE; CANADA; COMORBIDITY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; POISSON DISTRIBUTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SOCIAL STATUS; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ALBERTA; COHORT STUDIES; COMORBIDITY; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84868556470     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs263     Document Type: Article

References (29)

1. Hemmelgarn BR, Manns BJ, Lloyd A et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010; 303: 423-429
2. Stevens LA, Viswanathan G, Weiner DE. Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis 2010; 17: 293-301
3. Peralta CA, Shlipak MG, Fan D et al. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2892-2899
4. Hallan SI, Vikse BE. Relationship between chronic kidney disease prevalence and end-stage renal disease risk. Curr Opin Nephrol Hypertens 2008; 17: 286-291
5. Astor BC, Matsushita K, Gansevoort RTet al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011; 79: 1331-1340
6. Rifkin DE, Shlipak MG, Katz R et al. Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 2008; 168: 2212-2218
7. Perkins R, Bucaloiu I, Kirchner H et al. GFR decline and mortality risk among patients with chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 1879-1886
8. Matsushita K, Selvin E, Bash LD et al. Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol 2009; 20: 2617-2624
9. Cheng TYD, Wen SF, Astor BC et al. Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan. Am J Kidney Dis 2008; 52: 1051-1060
10. Al-Aly Z, Zeringue A, Fu J et al. Rate of kidney function decline associates with mortality. J Am Soc Nephrol 2010; 21: 1961-1969
11. Hemmelgarn BR, Clement F, Manns BJ et al. Overview of the Alberta kidney disease network. BMC Nephrol 2009; 10: 30
12. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
13. Ethnocultural portrait of Canada highlight tables, 2006 census. Statistics Canada. http://www12.statcan.ca/english/census06/data/highlights/ ethnic/index.cfm?Lang=E. (15 June 2010, date last accessed)
14. Bash LD, Coresh J, Köttgen A et al. Defining incident chronic kidney disease in the research setting. Am J Epidemiol 2009; 170: 414-425
15. Gowans E, Fraser C. Biological variation of serum and urine creatinine and creatinine clearance: ramifications for interpretation of results and patient care. Ann Clin Biochem 1988; 25: 259-263
16. Hölzel WG. Intra-individual variation of some analytes in serum of patients with chronic renal failure. Clin Chem 1987; 33: 670-673
17. Premium assistance program: premium subsidy. 2010. (5 October 2011, date last accessed at http://www.health.alberta.ca/AHCIP/premium-subsidy.html.)
18. Hux JE, Ivis F, Flintoft V et al. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002; 25: 512-516
19. Quan H, Khan N, Hemmelgarn BR et al. Validation of a case definition to define hypertension using administrative data. Hypertension 2009; 54: 1423-1428
20. Quan H, Sundararajan V, Halfon P et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43: 1130-1139
21. Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem 2009; 46: 205-217
22. Manns BJ, Mortis GP, Taub KJ et al. The Southern Alberta Renal Program database: a prototype for patient management and research initiatives. Clin Invest Med 2001; 24: 164-170
23. Gardner W, Mulvey E, Shaw E. Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models. Psychol Bull 1995; 118: 392-404
24. Lee P, Johansen K, Hsu C. End-stage renal disease preceded by rapid declines in kidney function: a case series. BMC Nephrol 2011; 12: 5
25. Lambers Heerspink HJ, Perkovic V, de Zeeuw D. Is doubling of serum creatinine a valid clinical 'hard' endpoint in clinical nephrology trials? Nephr Clin Pract 2011; 119: 195-199
26. Richards N, Harris K, Whitfield M et al. Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes. Nephrol Dial Transplant 2008; 23: 549-555
27. Bayliss EA, Bhardwaja B, Ross C et al. Multidisciplinary team care may slow the rate of decline in renal function. Clin J Am Soc Nephrol 2011; 6: 704-710
28. Lewis J, Greene T, Appel L et al. A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol 2004; 15: 3175-3183
29. Agodoa LY, Appel L, Bakris GL et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis. JAMA 2001; 285: 2719-2728